Biotech and pharma companies hire Pharmagellan when their own teams are stretched too thin to realize the full value of their R&D portfolios.
Pharmagellan fills the gap with wide-ranging expertise – from designing biomarker strategies and clinical trials, to assessing market opportunities and building financial models, to presenting before your board or portfolio review committee. That breadth of ability allows us to adapt as your needs grow and your pipeline progresses.
Pharmagellan is a rarity among biotech consultants: a firm that thinks big picture but also executes the specifics.
RESEARCH + DEVELOPMENT
IND-enabling preclinical data analysis
Translational science and biomarker strategy
Next-gen sequencing and immuno-oncology strategy, execution, and outsourcing
Patient selection and sample handling logistics
Clinical development strategy and trial design
Collaborator identification and engagement
- Opportunity assessment
Forecasting and valuation
M&A/partnering strategy and execution support
Due diligence and in-licensing support
Competitive intelligence and positioning
Alternate commercial and financing models